SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
---|---|---|---|---|---|---|---|---|
30-Jun-23 2:34 PM View: | Ultragenyx Pharmaceutical I... (RARE) | 30-Jun-23 | Sale (Planned) | 585 | $46.76 | $27,354.60 | (6%) 9.57K to 8.98K | |
27-Jun-23 5:21 PM View: | Beigene, Ltd. (BGNE) | 23-Jun-23 | Sale (Planned) | 578 | $182.32 | $105,381.00 | (2%) 30.48K to 29.9K | |
09-Jun-23 2:31 PM View: | Ultragenyx Pharmaceutical I... (RARE) | 08-Jun-23 | Sale (Planned) | 1,485 | $51.65 | $76,700.20 | (13%) 11.05K to 9.57K | |
09-Jun-23 2:31 PM View: | Ultragenyx Pharmaceutical I... (RARE) | 07-Jun-23 | Grant | 3,860 | -- | -- | 54% 7.2K to 11.05K | |
29-Jun-22 3:48 PM View: | Ultragenyx Pharmaceutical I... (RARE) | 24-Jun-22 | Grant | 3,300 | -- | -- | 85% 3.9K to 7.2K | |
24-Jun-22 5:37 PM View: | Beigene, Ltd. (BGNE) | 22-Jun-22 | Grant | 16,692 | -- | -- | 214% 7.8K to 24.49K | |
30-Jun-21 7:58 PM View: | Ultragenyx Pharmaceutical I... (RARE) | 29-Jun-21 | Grant | 3,895 | -- | -- | 100% 0 to 3.9K | |
21-Jun-21 4:35 PM View: | Beigene, Ltd. (BGNE) | 16-Jun-21 | Grant | 7,800 | -- | -- | 100% 0 to 7.8K |